Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

The FDA has cleared Dexcom’s Stelo ... sites at knockdown prices, raising questions about their quality and/or authenticity. Dexcom has said it intends to launch Stelo in the summer, but has ...

DexCom issued its outlook for 2025 revenues. This guidance assumes continued strong category growth, steady DME share, new access wins internationally, broader distribution for Stelo and several ...

DexCom, Inc. DXCM is scheduled to release fourth ... strong international performance and the growing traction of Stelo are key factors driving optimism. Additionally, regulatory progress with ...

The stocks are ranked in ascending order of hedge ... in EBITDA. DexCom, Inc. (NASDAQ:DXCM) is expanding its market reach beyond traditional insulin management through Stelo, its first over ...

Recent areas of focus include the introduction of their G7 system and further development of offerings like the Dexcom Stelo, targeting non-insulin-using diabetes patients. During Q4 2024 ...